Looking for a BREAKOUT Nasdaq Stock for Tuesday? $VCEL
Manic Stock Alerts We Are Looking at VCEL Verical Corp. Tomorrow and Looking at Her as a Swing Trade Not Just a Hit & Run Trading Idea. This Baby Has Climbed Above her Weekly 50ma Resistance and This Chart Has Huge Upside Potential!
This Chart Has Been Waiting for a Catalyst and Think We Saw This with Last Nights Earnings Press Release! Vericel ReportsTotal Revenues of $14.7 Million Reported for the Fourth Quarter
Could VCEL Be Setting Up to Head Towards 2012 Highs of Over 69.00 a Share??
Website:http://www.vcel.com/ Developing Patient Specific Expanded Cellular Therapies
Vericel Corporation (formerly Aastrom Biosciences) is the leader in developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns comprising greater than or equal to 30% of total body surface area. Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-T, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.